Board Members

  • Prof Andrew McLachlan

    Prof Andrew McLachlan AM (Chair)

    Professor Andrew McLachlan is a pharmacist and researcher with experience in clinical and experimental pharmacology and research into the quality use of medicines.

    Professor McLachlan is the Head of School and Dean of Pharmacy at the University of Sydney and former Chair of the Sydney Local Health District-Concord Hospital Ethics Committee, Concord Hospital. He is actively involved in teaching and serves on expert committees related to medicines regulation, research evaluation, medication safety and anti-doping.

    In 2018, Professor McLachlan was named a Member of the Order of Australia for significant service to pharmacy as a researcher, educator and administrator, and to professional medical and scientific organisations.

  • Prof Fiona Blyth

    Prof Fiona Blyth AM (Deputy Chair)

    Professor Fiona Blyth is the Professor of Public Health and Pain Medicine, Head of Concord Clinical School & Associate Dean, Faculty of Medicine, University of Sydney. She is also a member of Research Ethics Committee & Section Editor, Topical Reviews, PAIN Journal.

    In 2018, she was named a Member of the Order of Australia for her significant contributions to medical research and education public health, pain management and aging, and health policy reform.

  • gclark_portrait

    A/Prof Georgina Clark

    A/Prof Georgina Clark completed her PhD at the University of Melbourne in molecular immunology in the early days of cloning cell surface molecules. She continued her studies on leucocyte surface molecules undertaking postdoctoral work at the Nuffield Department of Surgery, University of Oxford, UK. Following Oxford, A/Prof Clark moved to the Canterbury Health Laboratories in Christchurch New Zealand and the Christchurch Medical School at University of Otago, New Zealand where she joined Professor Hart’s group studying the molecules found on the surface of dendritic cells. A/Prof Clark was instrumental in setting up the Mater Medical Research Institute in Queensland, lead a proteomics project for the Cooperative Research Centre for Biomarker Translation before joining the ANZAC Research Institute in 2010.

    A/Prof Clark set up Dendritic Cell Research (DCR) at the ANZAC Research Institute alongside the late Professor Derek Hart. Her interest lies in translational research developing antibodies to leucocyte surface molecules into immune therapies. In 2021 A/Prof Clark became the Acting Director of the ANZAC Research Institute.

  • Dr Teresa Anderson

    Dr Teresa Anderson AM

    Dr Teresa Anderson is the Chief Executive of Sydney Local Health District, one of the leading public health services in Australia. She has more than 35 years of experience as a clinician and health service executive. She has a well-established reputation for implementing strategies to foster innovation and best practice, supporting collaboration and building partnerships.

    She is an internationally recognised Speech Pathologist and is passionate about developing programs and services to support and improve the health and wellbeing of all people in the community. In 2018 Dr Anderson was appointed a Member of the Order of Australia (AM).

    Dr Anderson is a Vice President and has been made a Fellow of the NSW Institute of Public Administration Australia, is a member of seven Medical Research, Health and PHN boards and is an active member of the Sydney Health Partners Governing Council and Executive Management Group, one of the first four centres in Australia designated by the NHMRC as an Advanced Health Research Translation Centre.

  • A/Prof Ilona Cunningham

    A/Prof Ilona Cunningham

    A/Prof Ilona Cunningham is a Senior Staff Specialist, Head of Department, for the Department of Haematology at Concord Repatriation General Hospital.

    She is a fellow of the Royal Australasian College of Physicians, Haematology Society of Australia & New Zealand, Australasian Leukaemia & Lymphoma Study Group, Australasian Society of Thrombosis and Haemostasis & American Society of Haematology.

  • found_board_gdavidson

    Ms. Gillian Davidson

    Ms Gillian Davidson is a Partner, Commercial Insurance with Sparke Helmore Lawyers. She is currently a member of Global Insurance Law Connect (GILC) board and chairs the Asia Pacific regional group. GILC is a global network of specialist independent firms specialising in insurance law, of which Sparke Helmore became a member in February 2019.

    Ms Davidson's current Board appointments include: Global Insurance Law Connect, Member, Chair of Asia Pacific Regional Board; Appellate Tribunal Anglican Church, Tribunal Member; General Synod of the Anglican Church, Member; Katoomba Christian Convention, Director.

  • Mr George Elias

    Mr George Elias

    Mr George Elias is a Principal of Elias Financial Services and is an Authorised Representative of Count Financial Limited.

    Mr Elias has been providing financial / accounting advice as principal of Elias Financial Services since July 1991 to a wide range of personal and small/medium business clients, and he has been providing investment advice as an authorized representative of Count since June 1992. In February 2000, CPA Australia designated George a Financial Planning Specialist. George also specialises in tax effective loan structuring drawing on his experience as a tax advisor and mortgage broker. George is also the chairman of an ASX listed company and a member of the Australian Institute of Company Directors.

  • A/Prof Meng Ngu

    A/Prof Meng Ngu OAM

    A/Prof Meng Ngu is a Senior Staff Specialist, Head of Gastroenterology and Hepatology Department Chairman, Ambulatory Care & Endoscopy at Concord Repatriation General Hospital. He is also a Clinical Assoc Professor, University of Sydney, Concord RGH Clinical School and Trustee and member of Management Committee of the Rights of Private Practice Trust Fund.

    He is a Member of the following Professional Associations: Fellow of the Royal Australasian College of Physicians; Fellow of American Gastroenterological Association; Gastroenterological Society of Australia; Australian Medical Association; Australian Chinese Medical Association; European Association for the Study of Liver Diseases and Asian Pacific Association for the Study of Liver Diseases.

  • found_board_markrees

    Prof Mark Rees

    Professor Mark Rees' academic interests lie in the genetic basis of medical disorders with a recent focus on neurology, mental health and cardio-respiratory disease. Professor Rees is former Founder / Director of the Wales Epilepsy Research Network and a Fellow of the Royal College of Pathologists and Fellow of the Learned Society for Wales.

    In April 2019, he joined the University of Sydney as Deputy-Executive Dean of Research Partnerships for the Faculty of Medicine and Health (FMH). He is focusing on growing the research capacity of FMH and deliver stronger collaborative partnerships with USYD-affiliated MRI’s and NSW-LHD’s.

  • Dr Tim Sinclair

    Dr Tim Sinclair

    Dr Tim Sinclair is currently the Executive Director of Operations, Sydney Local Health District SLHD. He holds a Doctor of Business Administration, a Masters in Health Services Management and a Bachelor of Applied Science (Health Information Management). He was the Chief Operating Officer at the Alfred Health Service, Melbourne and has also served as the General Manager of Concord Repatriation General Hospital and Balmain Hospital. He has previously held a number of other senior positions with the then Sydney South West Area Health Service including the Associate Director of Clinical Operations and the Manager, Operational Initiatives.

    Dr Sinclair also successfully completed the Graduate Health Management Training Program.  He is also a Director on the ANZAC Health and Medical Research Foundation. In 2013 Dr Sinclair was also the recipient of the Institute of Public Administration Australia award for Individual Excellence and the Anthea Kerr Award.